TP53 and endometrial carcinoma: The Cancer Genome Atlas stratifies endometrial carcinomas into four distinct molecular groups on the basis of molecular genetic alterations, namely those with Defective DNA polymerase ε (POLE) mutations, those with MSI, those with low copy number alterations, and those with high copy number alterations, including p53 mutations.